Home » Health and medicine » COVID-19 » SynBioBeta Live: The New Diagnostics Marketplace in a Post-COVID world

SynBioBeta Live: The New Diagnostics Marketplace in a Post-COVID world

Friday, April 24, 2020, 8 am PDT

Brought to you by:


The COVID-19 pandemic has exposed life-threatening gaps in our ability to conduct the widespread community testing needed to mount an effective public health response. Companies, universities, and investors have taken the initiative to form new partnerships that are not only helping us overcome this pandemic, but may also become an enduring ecosystem capable of bringing unprecedented diagnostics to the health care market in days, not years. Join SynBioBeta founder John Cumbers as we explore this new ecosystem with a diverse panel of distinguished experts.

  • Esther Dyson, Chairman of EDventure Holdings and Executive Founder of Wellville
  • Trevor Martin, Co-Founder and CEO of Mammoth Biosciences
  • Ursheet Parikh, Partner at Mayfield
  • Jack Regan, CEO & Founder of LexaGene
  • Lee Hampton, Senior Specialist at GAVI
  • Jyri Engestrom, Partner and Co-founder at Yes VC



Kevin Costa

As Editor and Program Manager, Kevin leads SynBioBeta's digital media content, with the goal of telling the story of the people, companies, and ideas shaping the future with biology. Before joining SynBioBeta, Kevin managed the Synthetic Biology Engineering Research Center. His interests include public engagement, science writing, community building, and bikes!

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Add comment

Job opportunities